Condition: Cancer · Sponsor: Tempus AI
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
This description comes directly from the study's public registry record.
Lauren Lopez · 8007394137 · aries@tempus.com
Always discuss trial participation with your own doctor first.
| Alabama Oncology | Birmingham, Alabama, United States | Recruiting |
| PIH Health Whittier Hospital & PIH Health Physicians | Whittier, California, United States | Recruiting |
| Eastern CT and Hematology and Oncology Associates | Norwich, Connecticut, United States | Recruiting |
| Cancer Specialists of North Florida | Jacksonville, Florida, United States | Recruiting |
| Morehouse | Atlanta, Georgia, United States | Recruiting |
| Piedmont Healthcare | Atlanta, Georgia, United States | Recruiting |
| Southern Illinois Healthcare | Carterville, Illinois, United States | Recruiting |
| Hope and Healing Cancer Services | Hinsdale, Illinois, United States | Recruiting |
| Cancer Care Specialists of Illinois | O'Fallon, Illinois, United States | Recruiting |
| Illinois Cancer Care | Peoria, Illinois, United States | Recruiting |
| Northwest Oncology and Hematology | Rolling Meadows, Illinois, United States | Terminated |
| Fort Wayne | Fort Wayne, Indiana, United States | Terminated |
+ 20 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.